Meet the media team
Find a media contact in your region
Learn more
Total 99 Results for:
Showing 12 out of 99 results
23 juin 2026
Herbert Smith Freehills Kramer advises the sole sponsor on HJ Science’s Hong Kong IPO
Leading global law firm Herbert Smith Freehills Kramer has advised CITIC Securities (Hong Kong) Limited as the sole sponsor on HJ Science Co., Ltd. …
12 juin 2026
Herbert Smith Freehills Kramer advises on the financing for GSK plc's US$10.6 billion acquisition of Nuvalent Inc.
Leading global law firm Herbert Smith Freehills Kramer has advised the arranging banks on the financing to support the proposed US$10.6 billion …
1 juin 2026
Herbert Smith Freehills Kramer advises placing agents on CARsgen Therapeutics' HK$470 million Hong Kong share placement
Leading global law firm Herbert Smith Freehills Kramer has advised UBS AG Hong Kong Branch and Macquarie Capital Limited, the joint placing agents to …
15 mai 2026
Herbert Smith Freehills Kewei advises Fosun Pharma on option agreement with AriBio for territories including the US, Europe and Japan
Leading global law firm Herbert Smith Freehills Kramer and its China joint operation partner Kewei have advised China pharmaceutical giant Fosun Pharma …
28 avril 2026
Herbert Smith Freehills Kramer advises joint sponsors on Mabwell’s Hong Kong IPO
Leading global law firm Herbert Smith Freehills Kramer has advised CITIC Securities (Hong Kong) Limited and Haitong International Capital Limited as …
19 février 2026
Herbert Smith Freehills Kramer advises Morrison on acquisition of SuperFreeze Singapore
Leading international law firm Herbert Smith Freehills Kramer has advised Morrison, a global infrastructure investment firm, on its acquisition of …
23 décembre 2025
Herbert Smith Freehills Kramer advises underwriters on QingSong Health's Hong Kong IPO
Leading global law firm Herbert Smith Freehills Kramer has advised China International Capital Corporation Hong Kong Securities Limited and China …
12 décembre 2025
Herbert Smith Freehills Kewei advises Fosun Pharma on international licence agreements with Pfizer and Sitala
International leading law firm Herbert Smith Freehills Kramer and its China joint operation partner Kewei have advised China’s pharmaceutical leader …
30 septembre 2025
Herbert Smith Freehills Kramer advises Lupin on acquisition of VISUfarma from GHO Capital
Leading international law firm Herbert Smith Freehills Kramer has advised Nanomi B.V., a Dutch subsidiary of Lupin Limited, on the acquisition of …
27 août 2025
Herbert Smith Freehills Kramer advises Mitsubishi Corporation on Southeast Asia healthcare investment
Herbert Smith Freehills Kramer has advised Mitsubishi Corporation on its investment in Fullerton Health from Fullerton Health Corporation.
15 août 2025
Herbert Smith Freehills Kramer advises underwriters of Innogen Pharma's Hong Kong IPO
Leading global law firm Herbert Smith Freehills Kramer has advised CITIC Securities (Hong Kong) Limited, CLSA Limited and China International Capital …
25 juillet 2025
Herbert Smith Freehills Kramer advises underwriters of Nanjing Leads Biolabs' Hong Kong IPO
Leading global law firm Herbert Smith Freehills Kramer has advised Morgan Stanley Asia Limited, CITIC Securities (Hong Kong) Limited and CLSA Limited as …
Showing 12 out of 99 results
View moreCode≠Law: In a race between innovation and oversight, which one sets the pace?
The second chapter of our series explores the forces shaping AI’s next phase and what they mean for business
Read our latest report